Vera J Suman Selected Research

Vera J Suman Research Topics

Disease

67	Breast Neoplasms (Breast Cancer) 06/2022 - 05/2002
64	Neoplasms (Cancer) 06/2022 - 06/2002
19	Melanoma (Melanoma, Malignant) 01/2021 - 06/2002
9	Disease Progression 01/2019 - 09/2003
7	Triple Negative Breast Neoplasms 06/2022 - 10/2014
7	Multiple Myeloma 01/2022 - 07/2018
5	Thyroid Neoplasms (Thyroid Cancer) 01/2020 - 10/2010
5	Neoplasm Metastasis (Metastasis) 10/2018 - 06/2002
3	Hypertension (High Blood Pressure) 08/2017 - 09/2012
3	Fatigue 08/2017 - 10/2010
3	Anaplastic Thyroid Carcinoma 01/2013 - 10/2010
2	Pathologic Complete Response 04/2017 - 01/2017
2	Ovarian Neoplasms (Ovarian Cancer) 02/2005 - 12/2003
2	Warts (Wart) 02/2005 - 12/2003
2	Carcinoma (Carcinomatosis) 08/2002 - 05/2002
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021
1	Residual Neoplasm 10/2020

Drug/Important Bio-Agent (IBA)

17	Tamoxifen FDA LinkGeneric 01/2020 - 09/2003
16	Estrogen ReceptorsIBA 01/2021 - 03/2006
13	Aromatase InhibitorsIBA 01/2022 - 09/2003
12	Trastuzumab (Herceptin)FDA Link 01/2021 - 06/2002
11	Paclitaxel (Taxol)FDA LinkGeneric 11/2014 - 10/2005
10	Pharmaceutical PreparationsIBA 06/2022 - 07/2006
8	Letrozole (Femara)FDA LinkGeneric 01/2020 - 09/2003
8	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 10/2017 - 12/2005
7	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 10/2009
7	Anastrozole (Arimidex)FDA LinkGeneric 01/2020 - 09/2003
7	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2014 - 04/2002
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2014 - 09/2004
6	pazopanib FDA Link 01/2020 - 10/2010
6	exemestane (Aromasin)FDA Link 01/2020 - 09/2003
6	Biomarkers (Surrogate Marker)IBA 01/2018 - 06/2007
6	ErbB Receptors (EGF Receptor)IBA 11/2014 - 09/2004
6	Carboplatin (JM8)FDA LinkGeneric 02/2013 - 01/2005
5	Phenobarbital (Luminal)FDA Link 06/2022 - 06/2011
5	4-hydroxy-N-desmethyltamoxifenIBA 01/2020 - 12/2005
4	Lenalidomide (CC 5013)FDA Link 01/2022 - 07/2018
4	Aromatase (CYP19)IBA 01/2020 - 01/2010
4	Estrogens (Estrogen)FDA Link 01/2020 - 04/2005
4	Hormones (Hormone)IBA 12/2017 - 10/2009
4	VaccinesIBA 01/2016 - 08/2006
3	Androgen Receptors (Androgen Receptor)IBA 06/2022 - 01/2017
3	taxaneIBA 01/2021 - 10/2012
3	Bevacizumab (Avastin)FDA Link 01/2020 - 01/2009
3	Estradiol (Delestrogen)FDA LinkGeneric 01/2020 - 08/2009
3	130-nm albumin-bound paclitaxelIBA 01/2020 - 04/2011
3	human ERBB2 proteinIBA 01/2019 - 11/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 01/2009
3	RNA (Ribonucleic Acid)IBA 01/2018 - 07/2004
3	Phosphotransferases (Kinase)IBA 08/2017 - 10/2010
3	Peptides (Polypeptides)IBA 01/2016 - 08/2006
3	ParaffinIBA 12/2014 - 12/2005
3	B 31IBA 11/2014 - 10/2005
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2011 - 08/2006
3	EnzymesIBA 01/2010 - 01/2007
2	Estrogen Receptor betaIBA 02/2022 - 10/2018
2	Bortezomib (Velcade)FDA Link 12/2021 - 07/2010
2	Immunomodulating AgentsIBA 12/2021 - 07/2018
2	Dexamethasone (Maxidex)FDA LinkGeneric 12/2021 - 01/2016
2	AnthracyclinesIBA 01/2021 - 12/2017
2	IpilimumabIBA 01/2020 - 07/2018
2	Everolimus FDA Link 01/2020 - 01/2018
2	Estrone FDA Link 01/2020 - 01/2010
2	Fulvestrant (Faslodex)FDA Link 01/2020 - 03/2006
2	Interleukin-2 (IL2)IBA 07/2018 - 10/2011
2	Cytostatic AgentsIBA 01/2018 - 12/2017
2	Estrogen Receptor alphaIBA 01/2018 - 11/2017
2	Progesterone Receptors (Progesterone Receptor)IBA 11/2017 - 03/2006
2	Proteins (Proteins, Gene)FDA Link 04/2017 - 06/2002
2	AntigensIBA 01/2016 - 12/2008
2	antineoplaston A10 (A 10)IBA 08/2015 - 08/2002
2	A-Form DNA (A-DNA)IBA 12/2014 - 01/2007
2	Temozolomide (Temodar)FDA LinkGeneric 02/2013 - 01/2012
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2013 - 09/2012
2	Monatide (IMS 3015)IBA 10/2011 - 08/2006
2	Protein Subunit VaccinesIBA 10/2011 - 08/2006
2	Tyrosine Kinase InhibitorsIBA 10/2010 - 04/2008
2	HLA-A2 Antigen (HLA A2 Antigen)IBA 12/2008 - 08/2006
2	Interleukin-17 (Interleukin 17)IBA 09/2008 - 04/2006
2	KW 2189IBA 01/2007 - 06/2002
2	Megestrol Acetate (Borea)FDA LinkGeneric 05/2005 - 12/2002
2	SuspensionsIBA 12/2002 - 05/2002
1	pomalidomideIBA 12/2021
1	ixazomibIBA 12/2021
1	Proteasome InhibitorsIBA 12/2021
1	InterferonsIBA 01/2021

Therapy/Procedure

44	Therapeutics 06/2022 - 06/2002
21	Drug Therapy (Chemotherapy) 03/2021 - 04/2002
12	Neoadjuvant Therapy 06/2022 - 01/2010
4	Lymph Node Excision (Lymph Node Dissection) 10/2020 - 10/2013
4	Adjuvant Chemotherapy 11/2014 - 10/2005
3	Immunotherapy 01/2021 - 07/2018
3	Aftercare (After-Treatment) 12/2017 - 03/2006
3	Drug Tapering 08/2017 - 10/2010
2	Stem Cell Transplantation 05/2021 - 01/2016
2	Brachytherapy 10/2020 - 08/2002
2	Salvage Therapy 01/2020 - 12/2003
2	Radiotherapy 03/2013 - 02/2005
2	Laparotomy 02/2005 - 12/2003